Table 2 Comparison of complications between two groups
COVID-19 (n = 165) | Non-COVID-19 (n = 210) | p | |
|---|---|---|---|
Pneumonia, no. (%) | 128 (77.58%) | 134 (63.80%) | 0.004 |
Pulmonary embolism, no. (%) | 17 (10.30%) | 10 (4.76%) | 0.039 |
DVT, no. (%) | 55 (33.33%) | 39 (18.57%) | 0.001 |
7 days delirium, no. (%) | 115 (69.70%) | 97 (46.19%) | 0.000 |
Respiratory failure, no. (%) | 63 (38.18%) | 52 (24.77%) | 0.005 |
Heart failure, no. (%) | 51 (30.91%) | 37 (17.62%) | 0.003 |
MODS, no. (%) | 44 (26.67%) | 28 (13.33%) | 0.001 |
Neurological deficit, no. (%) | 18 (10.91%) | 25 (11.90%) | 0.932 |
Abnormal liver enzymes, no. (%) | 81 (49.10%) | 93 (44.29%) | 0.354 |
Diarrhea, no. (%) | 64 (38.79%) | 69 (32.86%) | 0.233 |
Vomiting, no. (%) | 59 (35.76%) | 64 (30.48%) | 0.280 |
ICU length (day), mean ± SD | 8.46 ± 2.08 | 7.11 ± 1.92 | 0.001 |
Mechanical ventilation, no. (%) | 75 (45.45%) | 64 (30.48%) | 0.003 |